Yuji Wakamatsu

Yuji Wakamatsu

Auto-generated profile, based on publicly available information

Yuji Wakamatsu

Division of Cardiology, Department of Medicine, Nihon University School of Medicine , 30-1 Ohyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
TNToshiko Nakai
Toshiko Nakai
YIYukitoshi Ikeya
Yukitoshi Ikeya
RKRikitake Kogawa
Rikitake Kogawa
NONaoto Otsuka
Naoto Otsuka
YWYuji Wakamatsu
Yuji Wakamatsu
YOYasuo Okumura
Yasuo Okumura
Background: The definition of response to cardiac resynchronization therapy (CRT) varies across clinical trials. There are two main definitions, i.e., echocardiographic response and functional response. We assessed which definition was more reasonable. Methods: In this study of 260 patients who had undergone CRT, an echocardiographic response was defined as a reduction in a left ventricular end-systolic volume of greater than or equal to 15% or an improvement in left ventricular ejection fraction of greater than or equal to 5%. A functional response was defined as an improvement of at least one class category in the New York Heart Association functional classification. We assessed the response to CRT at 6 months after device implantation, based on each definition, and investigated the relationship between response and clinical outcomes. Results: The echocardiographic response rate was 74.2%. The functional response rate was 86.9%. Non-responder status, based on both definitions, was associated with higher all-cause mortality. Cardiac death was only associated with functional non-responder status (hazard ratio (HR) 2.65, 95% confidence interval (CI) 1.19–5.46, p = 0.0186) and heart failure hospitalization (HR 2.78, 95% CI, 1.29–5.26, p = 0.0111). Conclusion: After CRT implantation, the functional response definition of CRT response is associated with a higher response rate and better clinical outcomes than that of the echocardiographic response definition, and therefore it is reasonable to use the functional definition to assess CRT response.

18 February 2021 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
NONaoto Otsuka
Naoto Otsuka
YOYasuo Okumura
Yasuo Okumura
MAMasaru Arai
Masaru Arai
SKSayaka Kurokawa
Sayaka Kurokawa
KNKoichi Nagashima
Koichi Nagashima
YLYxin Li
Yxin Li

1 July 2020 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
YWYuji Wakamatsu
Yuji Wakamatsu
SNShiro Nakahara
Shiro Nakahara
KNKoichi Nagashima
Koichi Nagashima
RFReiko Fukuda
Reiko Fukuda
NNNaoki Nishiyama
Naoki Nishiyama
ITIsao Taguchi
Isao Taguchi

15 December 2023 in Journal of Arrhythmia
Verified
Journal Article
Open access
KNKoichi Nagashima
Koichi Nagashima
MMMitsunori Maruyama
Mitsunori Maruyama
YKYoshiaki Kaneko
Yoshiaki Kaneko
SSSatoshi Sakai
Satoshi Sakai
TSTakayuki Sekihara
Takayuki Sekihara
YOYasuo Okumura
Yasuo Okumura
Background: This study aimed to establish a systematic method for diagnosing atrioventricular nodal reentrant tachycardia (AVNRT) with a bystander concealed nodoventricular pathway (cNVP).Methods: We analyzed 13 cases of AVNRT with a bystander cNVP, 11 connected to the slow pathway (cNVP‐SP) and two to the fast pathway (cNVP‐FP), along with two cases of cNVP‐related orthodromic reciprocating tachycardia (ORT).Results: The diagnostic process was summarized in three steps. Step 1 was identification of the presence of an accessory pathway by resetting the tachycardia with delay (n = 9) and termination without atrial capture (n = 4) immediately after delivery of a His‐refractory premature ventricular contraction (PVC). Step 2 was exclusion of ORT by atrio‐His block during the tachycardia (n = 4), disappearance of the reset phenomenon after the early PVC (n = 7), or dissociation of His from the tachycardia during ventricular overdrive pacing (n = 1). Moreover, tachycardia reset/termination without the atrial capture (n = 2/2) 1 cycle after the His‐refractory PVC was specifically diagnostic. Exceptionally, the disappearance of the reset phenomenon was also observed in the two cNVP‐ORTs. Step 3 was verification of the AVN as the cNVP insertion site, evidenced by an atrial reset/block preceding the His reset/block in fast–slow AVNRT with a cNVP‐SP and slow–fast AVNRT with a cNVP‐FP or His reset preceding the atrial reset in slow–fast AVNRT with a cNVP‐SP.Conclusion: AVNRT with a bystander cNVP can be diagnosed in the three steps with few exceptions. Notably, tachycardia reset/termination without atrial capture one cycle after delivery of a His‐refractory PVC is specifically diagnostic.

1 March 2023 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Open access
YWYuji Wakamatsu
Yuji Wakamatsu
KNKoichi Nagashima
Koichi Nagashima
YKYoshiaki Kaneko
Yoshiaki Kaneko
HMHitoshi Mori
Hitoshi Mori
KTKenta Tsutsui
Kenta Tsutsui
YOYasuo Okumura
Yasuo Okumura

13 October 2018 in Journal of Arrhythmia
Verified
Journal Article
Open access
PDF file
KMKoyuru Monno
Koyuru Monno
YOYasuo Okumura
Yasuo Okumura
YSYuki Saito
Yuki Saito
YAYoshihiro Aizawa
Yoshihiro Aizawa
KNKoichi Nagashima
Koichi Nagashima
AHAtsushi Hirayama
Atsushi Hirayama
Background: Metabolic syndrome/epicardial adipose tissue (EAT) plays an important role in atrial fibrillation (AF). Although reverse atrial remodeling (RAR) often occurs after AF ablation, the effects of EAT on RAR remain unknown.Methods: Study subjects were 104 patients in whom transthoracic echocardiography (TTE) was performed before AF ablation and 3, 6, and 12 months afterward. EAT was assessed in terms of its thickness adjacent to the right ventricular anterior wall in the TTE parasternal view. RAR was defined as >10% reduction in the left atrial volume (LAV) index by the 3‐month follow‐up examination.Results: Postablation RAR occurred in 57/104 (55%) patients. RAR absence was associated with a relatively thick EAT (4.92 ± 1.65 vs. 3.92 ± 1.17 mm, P = 0.0005), small LAV index (24.6 ± 7.5 vs. 28.8 ± 10.6 mL/m2, P = 0.0233), and metabolic syndrome (62% vs. 28%, P = 0.0006). Metabolic syndrome and EAT were shown to be independent predictors of RAR absence. Thick EAT was significantly associated with AF recurrence after ablation (5.05 ± 2.19 mm vs. 4.17 ± 1.16 mm for no AF recurrence group, P = 0.0116), but metabolic syndrome was not (48% vs. 42%, P = 0.6189). Despite no change in body weight, EAT thickness decreased significantly by 12 months in patients without AF recurrence (4.17 ± 1.16 vs. 3.65 ± 1.16 mm, P < 0.0001).Conclusions: EAT and metabolic syndrome appear to be strongly associated with RAR absence, but only the thick EAT was significantly associated with the postablation AF recurrence. Our findings, especially the thinning of EAT, suggest that thick EAT lead to AF vulnerability but that EAT reduction favorably affects ablation outcome.